Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naipeng Cui

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|June 7, 2018
HER2-Based Immunotherapy for Breast CancerNaipeng Cui, Jianhong Shi, Chuanwei Yang
Stem Cells International|April 11, 2017
Cadherins Associate with Distinct Stem Cell-Related Transcription Factors to Coordinate the Maintenance of Stemness in Triple-Negative Breast CancerChuanwei Yang, Xuemei Zhao, Naipeng Cui, et al.
Zhonghua Yi Xue Za Zhi|October 15, 2014
[Roles of KLF5 in inhibition TNFα-induced SK-BR-3 breast cancer cell apoptosis]Jianhong Shi, Caiyun Liu, Anyi Zhang, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 6, 2019
Triphenylethylene-Coumarin Hybrid TCH-5c Suppresses Tumorigenic Progression in Breast Cancer Mainly Through the Inhibition of AngiogenesisNaipeng Cui, Dan-Dan Lin, Yang Shen, et al.
Chinese Medical Journal|April 9, 2014
Effector cells derived from naive T cells used in tumor immunotherapy of mice bearing B16 melanomaMing Wen, Weili Xu, Lili Ren, et al.
Frontiers in Oncology|October 2, 2019
Upregulation of OTUD7B (Cezanne) Promotes Tumor Progression via AKT/VEGF Pathway in Lung Squamous Carcinoma and AdenocarcinomaDan-Dan Lin, Yang Shen, Shu Qiao, et al.
Plos One|April 18, 2024
Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatmentLixia Liu, Meng Zhang, Naipeng Cui, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Biotherapy & Radiopharmaceuticals|June 7, 2018
HER2-Based Immunotherapy for Breast CancerNaipeng Cui, Jianhong Shi, Chuanwei Yang
Stem Cells International|April 11, 2017
Cadherins Associate with Distinct Stem Cell-Related Transcription Factors to Coordinate the Maintenance of Stemness in Triple-Negative Breast CancerChuanwei Yang, Xuemei Zhao, Naipeng Cui, et al.
Zhonghua Yi Xue Za Zhi|October 15, 2014
[Roles of KLF5 in inhibition TNFα-induced SK-BR-3 breast cancer cell apoptosis]Jianhong Shi, Caiyun Liu, Anyi Zhang, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 6, 2019
Triphenylethylene-Coumarin Hybrid TCH-5c Suppresses Tumorigenic Progression in Breast Cancer Mainly Through the Inhibition of AngiogenesisNaipeng Cui, Dan-Dan Lin, Yang Shen, et al.
Chinese Medical Journal|April 9, 2014
Effector cells derived from naive T cells used in tumor immunotherapy of mice bearing B16 melanomaMing Wen, Weili Xu, Lili Ren, et al.
Frontiers in Oncology|October 2, 2019
Upregulation of OTUD7B (Cezanne) Promotes Tumor Progression via AKT/VEGF Pathway in Lung Squamous Carcinoma and AdenocarcinomaDan-Dan Lin, Yang Shen, Shu Qiao, et al.
Plos One|April 18, 2024
Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatmentLixia Liu, Meng Zhang, Naipeng Cui, et al.
Pageof 1